...
首页> 外文期刊>Medical science monitor : >Acute pancreatitis: a literature review
【24h】

Acute pancreatitis: a literature review

机译:急性胰腺炎:文献综述

获取原文

摘要

Acute pancreatitis (AP) is an inflammatory disease characterized by steady, acute abdominal pain of varying severity, often radiating from the epigastrium to the back. Its presentation ranges from a self-limiting mild disorder to a more severe and fulminant disease. Severe acute pancreatitis accounts for 30% of all deaths related to pancreatitis. The incidence of AP is increasing progressively with a corresponding increase in the incidence of its risk factors. Alcohol abuse and gallstone migration are the established risk factors for development of AP. In recent years, genetic factors and obesity have also been identified as risk factors responsible for the development of AP. The pathophysiology of AP involves acute inflammation of the acinar cells. Excessive acinar cell injury leads to a condition called systemic inflammatory response syndrome (SIRS). Protracted SIRS is responsible for most of the life-threatening complications associated with AP. Most common AP-related complications include pulmonary, renal, cardiovascular, and central nervous system dysfunction. Thus prompt and accurate diagnosis of AP is of paramount importance. The medical management of AP includes controlling pain, providing adequate nutritional support, and monitoring complications. Endoscopic retrograde cholangiopancreatography and surgery have also shown to reduce the mortality and morbidity associated with AP. Drugs such as resveratrol and rosiglitazone are being investigated as potential candidates for the treatment of AP.
机译:急性胰腺炎(AP)是一种炎症性疾病,其特征是稳定,剧烈,不同程度的急性腹痛,通常从上腹向后方扩散。它的表现范围从自我限制的轻度疾病到更严重和暴发的疾病。重症急性胰腺炎占所有与胰腺炎相关的死亡的30%。 AP的发生率逐渐增加,其危险因素的发生率也相应增加。酗酒和胆结石迁移是AP发展的既定危险因素。近年来,遗传因素和肥胖也被确定为导致AP发生的危险因素。 AP的病理生理学涉及腺泡细胞的急性炎症。过度的腺泡细胞损伤导致称为全身性炎症反应综合征(SIRS)的疾病。长时间的SIRS会导致大多数与AP相关的威胁生命的并发症。与AP相关的最常见并发症包括肺,肾,心血管和中枢神经系统功能障碍。因此,迅速,准确地诊断AP至关重要。 AP的医疗管理包括控制疼痛,提供足够的营养支持以及监测并发症。内镜逆行胰胆管造影术和手术也已显示可降低与AP相关的死亡率和发病率。正在研究白藜芦醇和罗格列酮等药物作为治疗AP的潜在候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号